Technical Analysis for NVO - Novo Nordisk A/S

Grade Last Price % Change Price Change
A 101.41 -0.95% -0.97
NVO closed down 0.95 percent on Friday, September 17, 2021, on 1.38 times normal volume.

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent Up Up Up
Historical NVO trend table...

Date Alert Name Type % Chg
Fell Below 20 DMA Bearish 0.00%
Crossed Above 20 DMA Bullish -0.95%
Gapped Up Strength -0.95%
Up 3 Days in a Row Strength -0.95%
Up 4 Days in a Row Strength -0.95%
Up 5 Days in a Row Strength -0.95%
180 Bullish Setup Bullish Swing Setup 0.14%
Up 3 Days in a Row Strength 0.14%
Up 4 Days in a Row Strength 0.14%
Oversold Stochastic Weakness 0.14%
Older End-of-Day Signals for NVO ...

   Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

Get a Trading Assistant

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Novo Nordisk A/S Description

Novo Nordisk A/S engages in the discovery, development, manufacture, and marketing of pharmaceutical products primarily in Denmark. It operates in two segments, Diabetes Care and Biopharmaceuticals. The Diabetes Care segment covers insulins, GLP-1 analog, obesity, and oral antidiabetic drugs, as well as other protein related products comprising glucagon, protein related delivery systems, and needles. The Biopharmaceuticals segment offers products in the areas of haemophilia, growth hormone therapy, hormone replacement therapy, and inflammation. The company sells its products primarily in North America, China, Japan, Algeria, Argentina, Australia, Brazil, India, Turkey, and European countries through its subsidiaries, distributors, and independent agents. Novo Nordisk A/S was founded in 1925 and is headquartered in Bagsvaerd, Denmark.


Classification

Sector: Healthcare
Industry: Biotechnology
Keywords: Life Sciences Diabetes Pharmaceutical Products Inflammation Endocrine System Insulin Hormones Obesity Biopharmaceuticals Peptide Hormones Growth Hormone Glucagon Like Peptide 1 Pharmaceuticals Segment Anti Diabetic Drugs Diabetes Care Growth Hormone Therapy Haemophilia Hormone Therapy Novo Nordisk Related Delivery Systems

Is NVO a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 107.24
52 Week Low 63.22
Average Volume 1,077,229
200-Day Moving Average 79.96
50-Day Moving Average 97.37
20-Day Moving Average 101.84
10-Day Moving Average 100.67
Average True Range 1.50
ADX 22.78
+DI 28.26
-DI 26.55
Chandelier Exit (Long, 3 ATRs) 102.74
Chandelier Exit (Short, 3 ATRs) 103.56
Upper Bollinger Bands 105.76
Lower Bollinger Band 97.92
Percent B (%b) 0.45
BandWidth 7.69
MACD Line 0.70
MACD Signal Line 1.09
MACD Histogram -0.3879
Fundamentals Value
Market Cap 234.7 Billion
Num Shares 2.31 Billion
EPS 2.46
Price-to-Earnings (P/E) Ratio 41.19
Price-to-Sales 7.68
Price-to-Book 16.16
PEG Ratio 2.82
Dividend 1.04
Dividend Yield 1.03%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 103.44
Resistance 3 (R3) 103.50 102.90 103.10
Resistance 2 (R2) 102.90 102.38 102.86 102.99
Resistance 1 (R1) 102.15 102.06 101.85 102.09 102.87
Pivot Point 101.55 101.55 101.40 101.51 101.55
Support 1 (S1) 100.80 101.03 100.50 100.73 99.95
Support 2 (S2) 100.20 100.71 100.16 99.83
Support 3 (S3) 99.45 100.20 99.72
Support 4 (S4) 99.38